Journals / Ankara Üniversitesi Tıp Fakültesi Mecmuası / 2011 / Cilt: 64 - Sayı: 1

İntraoperatif radyofrekans ablasyon öncesi profilaktik amiodaron uygulaması

Prophylactic amiodarone administration before ıntraoperative radiofrequency ablation

Pages
30–35
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although the heart ratesat the time of admission were similar between groups (102,07±16,04 for amiodarone group and99,17±17,23 for control group, p=0,477), they were significantly lower in the amiodarone group atthe time of anesthesia induction (83,17±11,77, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study was designed to evaluate the effects of prophylactic amiodarone infusion onthe outcomes of intraoperative radiofrequency ablation.Design: Eighty patients who were scheduled for intraoperative radiofrequency ablation wereenrolled in this study and randomized into two groups: first group received 30mg/h amiodarone24 hours before the operation, and the second group received placebo.
📊
Key Findings & Data:Heart rates and cardiacrhythms in addition to clinical outcomes were measured during hospitalization and at the end ofthe 1stmonth.
💡
Conclusion & Impact:Although the heart ratesat the time of admission were similar between groups (102,07±16,04 for amiodarone group and99,17±17,23 for control group, p=0,477), they were significantly lower in the amiodarone group atthe time of anesthesia induction (83,17±11,77, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: This study was designed to evaluate the effects of prophylactic amiodarone infusion onthe outcomes of intraoperative radiofrequency ablation.Design: Eighty patients who were scheduled for intraoperative radiofrequency ablation wereenrolled in this study and randomized into two groups: first group received 30mg/h amiodarone24 hours before the operation, and the second group received placebo. Heart rates and cardiacrhythms in addition to clinical outcomes were measured during hospitalization and at the end ofthe 1stmonth. Results: The demographic and cardiac data were similar in both groups. Although the heart ratesat the time of admission were similar between groups (102,07±16,04 for amiodarone group and99,17±17,23 for control group, p=0,477), they were significantly lower in the amiodarone group atthe time of anesthesia induction (83,17±11,77, p

Özet

Giriş: Bu çalışma, profilaktik amiodaron tedavisinin intraoperatif radyofrekans ablasyonunun so- nuçları üzerine etkisini değerlendirmek amacıyla planlandı.Hastalar ve Yöntem: İntraoperatif radyofrekans ablasyonu uygulanmak üzere seçilen 80 hasta buçalışmaya katıldı ve bu hastalar 2 gruba randomize edildi: ilk grup operasyondan önce 24 saat sü- reyle 30mg/saat amiodaron alırken, 2. gruba plasebo verildi. Klinik çıktılara ek olarak kalp hızları vekalp ritmi hastanede kalım süresince ve 1. ayın sonunda kaydedildi.Bulgular: Demografik ve kardiyak bulgular her iki grupta da benzerdi. Her ne kadar hastaneyeyatırılma sırasındaki kalp hızları benzerse de (102,07±16,04 amiodaron grubu için ve 99,17±17,23kontrol grubu için, p=0,477), anestezi indiksüyonu (83,17±11,77, p

🔖

Cite This Article

ÖZYURDA, Ü., UYSALEL, A., UÇANOK, K., EYİLETEN, Z. B., AKAR, A., İNAN, M. B., ERYILMAZ, S., ŞIRLAK, M., YAZICIOĞLU, L. (2022). İntraoperatif radyofrekans ablasyon öncesi profilaktik amiodaron uygulaması. Ankara Üniversitesi Tıp Fakültesi Mecmuası, Cilt: 64 - Sayı: 1, 30–35. https://ajindex.com/articles/443786

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ostrander LD, Brandt RL, Kjelsberg MO, et al. Electrocardiographic findings among the adult population of a total natural com- munity, Tecumseh, Michigan. Circulation 1965; 31: 888-898.
  2. Ruchat P, Dang L, Schlaepfer J, et al. Use of a biophysical model of atrial fibrillation in the interpretation of the outcome of surgi- cal ablation procedures. European Journal of Cardio-thoracic Surgery 2007; 32: 90-95.
  3. Chua LY, Schaff HV, Orszulak TA, et al. Outcome of mitral valve repair in patients with preoperative atrial fibrillation. J Thorac Cardiovasc Surg 1994; 107(2): 408-415.
  4. Brodel GK, Cosgrove D, Schiavone W, et al. Cardiac rhythm and conduction disturbanc- es in patients undergoing mitral valve sur- gery. Cleve Clin J Med 1991; 58: 397-399.
  5. Large SR, Hosseinpour AR, Wisbey C, et al. Spontaneous cardioversion and mitral valve repair: a role for surgical cardioversion (Cox- maze)? Eur J Cardio-thorac Surg 1997: 11; 76-80.
  6. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent`risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-988.
  7. Cox JL, Schuessler RB, D’Agostino HJ Jr, et al. The surgical treatment of atrial fibril- lation. (III) Development of a definitive sur- gical procedure. J Thorac Cardiovasc Surg 1991; 101: 569-583.
  8. Handa N, Schaff HV, Morris JJ, et al. Out- come of valve repair and the Cox maze pro- cedure for mitral regurgitation and associ- ated atrial fibrillation. J Thorac Cardiovasc Surg 1999; 118: 626-635.
  9. Cox JL, Schuessler RB, Lappas DG, et al. An 8 1/2-year clinical experience with surgery for atrial fibrillation. Ann Surg 1996; 224: 267-273.
  10. Isobe F, Kawashima Y. The outcome and in- dications of the Cox maze III procedure for chronic atrial fibrillation with mitral valve disease. J Thorac Cardiovasc Surg 1998; 116: 220-227.
  11. Izumoto H, Kawazoe K, Eishi K, et al. Me- dium-term results after the modified Cox/ Maze procedure combined with other car- diac surgery. Eur J Cardiothorac Surg 2000; 17: 25-29.
  12. Cox JL, Ad N, Palazzo T, et al. The Maze-III procedure combined with valve surgery. Se- min Thorac Thorac Cardiovasc Surg 2000; 12: 53-55.
  13. Prasad SM, Maniar HS, Camillo CJ, et al. The Cox maze III procedure for atrial fibril- lation: long-term efficacy in patients under- going lone versus concomitant procedures. J Thorac Cardiovasc Surg 2003; 126: 1822- 1828. Doty DB. Surgical treatment of atrial fibril- lation. Heart Lung Circ. 2004; 13: 280-287.
  14. Kim KC, Cho KR, Kim YJ, et al. Long-term results of the Cox-Maze III